Salamanders regrow entire limbs. Mice, like humans, grow scar tissue instead. A study published in Science now offers a molecular explanation for that divide, and it comes down to something deceptively simple: how cells sense oxygen.
Researchers found that a single protein, HIF1A, acts as a biological switch that determines whether an amputated limb begins healing toward regrowth or defaults to scarring. When the team stabilized HIF1A in embryonic mouse limbs exposed to low-oxygen conditions, the tissue responded with rapid wound closure and cellular changes that mirror the earliest steps of salamander limb regeneration. Under normal atmospheric oxygen, those same limbs simply scarred over.
A protein that mammals destroy too quickly
The mechanism hinges on a difference in molecular housekeeping between species. In mammals, oxygen-dependent enzymes called prolyl hydroxylases tag HIF1A for rapid destruction whenever oxygen levels are normal. The protein gets broken down before it can activate downstream regenerative programs. Amphibians like axolotls handle things differently. Their cells maintain what researchers describe as a low oxygen-sensing capacity, keeping HIF1A stable and active long enough to drive the cellular reprogramming that limb regrowth requires.
That distinction reframes a long-standing question in regenerative biology. The barrier to mammalian limb regeneration may not be the absence of the right genes. Instead, it appears that mammals suppress a regenerative trigger by destroying HIF1A too quickly. The genes downstream of that protein are present in mice and humans alike. They just never receive the signal to activate.
Independent research supports the broader pattern. Work on Xenopus frogs has shown that early redox signals, biochemically linked to hypoxia and HIF1A stabilization, modulate tail regeneration. Oxygen-related pathways appear repeatedly across animals that can regrow lost body parts, making the new finding part of a coherent biological theme rather than an isolated result.
The gap between embryonic tissue and a living adult
The most important caveat is that these experiments used embryonic mouse limbs, not adult ones. Embryonic cells retain developmental flexibility that adult mammalian cells have largely lost. Whether stabilizing HIF1A in mature tissue could produce a similar regenerative priming effect has not been tested. The distance between embryonic limbs cultured in a lab dish and a living adult mammal is substantial, and no published data bridges that gap for limb regeneration.
Partial evidence from other mammalian studies offers cautious encouragement. HIF1A in immune cells has been shown to be necessary for effective skeletal muscle repair in mice, and pharmacologic activation of the HIF1A pathway can accelerate bone healing. These results confirm that oxygen-sensing machinery plays causal roles in mammalian tissue repair. But muscle healing and bone mending are far simpler biological tasks than regrowing a complete limb with bones, nerves, blood vessels, and skin arranged in the correct architecture.
No human-specific experiments have been reported. Drugs that inhibit prolyl hydroxylase enzymes, which would stabilize HIF1A, already exist and are approved for clinical use in treating renal anemia. Yet no clinical trial has tested whether these compounds could trigger regenerative initiation in human wound tissue. The theoretical path from oxygen sensing to limb regrowth in people remains uncharted.
What this changes about the regeneration problem
For years, the working assumption in regenerative medicine was that mammals simply lack the biological toolkit for limb regrowth. This study challenges that framing. The toolkit appears to be present. What mammals lack is the trigger: a stable, persistent HIF1A signal at the wound site during a critical window after injury.
The primary evidence is the Science paper itself, which presents original experimental data from embryonic mouse limbs under controlled oxygen conditions. The researchers traced a mechanistic chain from subatmospheric oxygen through HIF1A stabilization to wound closure and changes in the histone landscape, the molecular packaging around DNA that determines which genes cells can access. Supporting studies on axolotl development, Xenopus tail regrowth, and cross-species regenerative genomics provide corroborating context showing that this oxygen-sensing logic is not unique to one species or one experiment.
The practical question now is whether anyone can flip this switch in adult mammalian tissue. The drugs to stabilize HIF1A already exist. The target is identified. What remains unknown is whether delivering that signal to the right cells, at the right dose, in the right time window after amputation could push adult tissue past its scarring default and toward genuine regrowth. That experiment has not been done. But for the first time, the field has a specific, druggable mechanism to test, and a clear reason to believe the problem is one of suppression, not absence.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
